Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CASTLE BIOSCIENCES INC Director's Dealing 2020

Apr 3, 2020

32601_dirs_2020-04-03_b8285d0c-8d6d-4a5e-baf6-6c3be1b11d1b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2020-04-01

Reporting Person: Harrison Miles (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-04-01 Stock option (right to buy) $28.77 A 16000 Acquired 2030-03-31 Common Stock (16000.0) Direct

Footnotes

F1: One-third of the shares shall vest on April 15, 2021, and the remaining shares shall vest in 24 equal monthly installments thereafter.